Dallas, Texas 75390


This study will train Lay Health Promoters (LHPs) from African-American churches to administer healthy living lessons and activities to their congregations in order to improve overall health and address cardiovascular disease. The primary hypothesis is that LHP training combined with a well supported maintenance strategy will be more effective than LHP training alone in reducing risk factors for cardiovascular disease.

Study summary:

The GoodNEWS Trial is an 18-month effectiveness trial with an 18-month extended maintenance study, among 20 African-American and low-income congregations participating in the GoodNEWS faith-based lay health promotion program. After training, congregations will be randomized to either GoodNEWS with a health maintenance intervention (GoodNEWS-I) or GoodNEWS program alone (GoodNEWS-PA). The maintenance intervention combines elements of the medical care model and features of community-based support. Primary data collection will occur at baseline, 18, and 36 months with the two primary outcomes being levels of physical activity as measured by 7- Day Physical Activity Recall (PAR) and dietary change as measured by the Diet History Questionnaire (DHQ). The primary hypothesis is that the maintenance group will significantly increase physical activity and healthy eating behavior compared to the program only group. We also hypothesize that lipoprotein and glucose levels, and blood pressure will be significantly improved over baseline in the GoodNEWS-I group and that these changes will be significantly greater than in the GoodNEWS-PA group. At the end of the trial, both groups will continue in an 18-month extended maintenance study.


Inclusion Criteria: - Member of selected church congregations in the predominantly African-American geographical area of Dallas, Texas, known as South Dallas or the Southern Sector. - Between the ages of 18 -70 years Exclusion Criteria: - Anyone under the age of 18 - Anyone who is not an active member of one of the participating churches



Primary Contact:

Principal Investigator
Mark J. DeHaven, Ph.D.
UT Southwestern Medical Center at Dallas

Mark J. DeHaven, Ph.D.
Phone: 214-648-2974
Email: Mark.DeHaven@UTSouthwestern.edu

Backup Contact:

Email: Natalie.Hsieh@UTSouthwestern.edu
Natalie Hsieh, M.S.
Phone: 214-648-2012

Location Contact:

Dallas, Texas 75390
United States

Mark J. DeHaven, Ph.D.
Phone: 214-648-2974
Email: mark.dehaven@utsouthwestern.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.